Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Candida cylindracea lipase** is an extracellular enzyme belonging to the triacylglycerol acyl hydrolase family (EC 3.1.1.3), purified from the yeast Candida cylindracea. It catalyzes the hydrolysis of triglycerides to free fatty acids and glycerol. The enzyme preparation contains multiple isoenzymes, which differ in their glycosylation, hydrophobicity, substrate specificity, and stability to pH and temperature. It is a serine hydrolase and functions without cofactors. It is widely used as a biocatalyst in industries including food (cheese, edible oils, baking), flavor production, pharmaceuticals, detergents, and biodiesel manufacturing, due to its broad substrate specificity and stability. The enzyme is recognized as GRAS (Generally Recognized as Safe) for use in food processing[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on candida cylindracea lipase.